Trial Profile
Phase IIb trial of ACH 1625 in combination with peginterferon and ribavirin in treatment-naive patients with genotype 1 hepatitis C.
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 22 Nov 2011
Price :
$35
*
At a glance
- Drugs Peginterferon (Primary) ; Ribavirin (Primary) ; Sovaprevir (Primary)
- Indications Hepatitis C
- Focus Therapeutic Use
- 22 Nov 2011 New trial record